miRNA-381 may target multidrug resistance proteins (ABCG2, ABCC3, ABCC5) and stemness factors, enhancing glioblastoma sensitivity to temozolomide,587 while reducing the molecular level of miRNA-318 can lead to drug resistance in glioblastoma. The gene discussed is ABCG2; the disease is glioblastoma.